ZAP70 expression was also down-regulated in HNSCC, and its involvement in the predictive risk model of HNSCC patients in the high-risk group revealed a comparatively lower amount of immune cell infiltration and a shorter survival time (51). Here, ZAP70 is linked to head and neck squamous cell carcinoma.